CliffBio
small molecule

CLARITIN-D

LORATADINE; PSEUDOEPHEDRINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLARITIN-D
Active ingredientLORATADINE; PSEUDOEPHEDRINE SULFATE
Strength5MG;120MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalNovember 2002
Marketing statusOTC

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.